...
首页> 外文期刊>Therapeutic advances in respiratory disease. >Risk factor analysis of nosocomial lower respiratory tract infection in influenza-related acute respiratory distress syndrome
【24h】

Risk factor analysis of nosocomial lower respiratory tract infection in influenza-related acute respiratory distress syndrome

机译:流感相关急性呼吸窘迫综合征中医院下呼吸道感染的风险因子分析

获取原文

摘要

Background: Patients with severe influenza-related acute respiratory distress syndrome (ARDS) have high morbidity and mortality. Moreover, nosocomial lower respiratory tract infection (NLRTI) complicates their clinical management and possibly worsens their outcomes. This study aimed to explore the clinical features and impact of NLRTI in patients with severe influenza-related ARDS. Methods: This was an institutional review board approved, retrospective, observational study conducted in eight medical centers in Taiwan. From January 1 to March 31 in 2016, subjects were enrolled from intensive care units (ICUs) with virology-proven influenza pneumonia, while all of those patients with ARDS requiring invasive mechanical ventilation and without bacterial community-acquired pneumonia (CAP) were analyzed. Baseline characteristics, critical-illness data and clinical outcomes were recorded. Results: Among the 316 screened patients with severe influenza pneumonia, 250 with acute respiratory failure requiring intubation met the criteria of ARDS, without having bacterial CAP. Among them, 72 patients developed NLRTI. The independent risk factors for NLRTI included immunosuppressant use before influenza infection [odds ratio (OR), 5.669; 95% confidence interval (CI), 1.770–18.154], extracorporeal membrane oxygenation (ECMO) use after ARDS (OR, 2.440; 95% CI, 1.214–4.904) and larger corticosteroid dosage after ARDS (OR, 1.209; 95% CI, 1.038–1.407). Patients with NLRTI had higher in-hospital mortality and longer ICU stay, hospitalization and duration on mechanical ventilation. Conclusion: We found that immunosuppressant use before influenza infection, ECMO use, and larger steroid dosage after ARDS independently predict NLRTI in influenza-related ARDS. Moreover, NLRTI results in poorer outcomes in patients with severe influenza. The reviews of this paper are available via the supplemental material section.
机译:背景:严重流感相关的急性呼吸窘迫综合征(ARDS)的患者具有高发病率和死亡率。此外,医院下呼吸道感染(NLRTI)使其临床管理变得复杂,并且可能会使其结果恶化。本研究旨在探讨NLRTI对患有严重流感相关ARDS患者的临床特征和影响。方法:这是一个制度审查委员会批准,回顾性,观察研究,在台湾的八个医疗中心进行。从1月1日至3月31日,2016年,受试者从重症监护单位(ICU)注册了病毒学普查的流感肺炎,而所有这些患者患有侵入机械通气和没有细菌群落的肺炎(盖子)的患者。记录基线特征,临界数据和临床结果。结果:316例筛选患有严重流感肺炎的患者,250例,急性呼吸衰竭需要插管符合ARDS的标准,而无需细菌盖。其中,72名患者开发出NLRTI。 NLRTI的独立危险因素包括流感感染前的免疫抑制剂使用[赔率比(或),5.669; 95%置信区间(CI),1.770-18.154],体外膜氧合(ECMO)在ARDS(或2.440; 95%CI,1.214-4.904)和ARDS之后的较大皮质类固醇剂量(或1.209; 95%CI, 1.038-1.407)。患有NLRTI的患者在医院内部死亡率较高,ICU的寿命更长,住院和机械通气的持续时间。结论:我们发现在流感感染,ECMO使用和较大的类固醇剂量之前使用的免疫抑制剂使用独立预测流感相关的ARDS中的NLRTI。此外,NLRTI导致严重流感患者的较差的结果。本文的评论可通过“补充”材料段。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号